Literature DB >> 17326891

Seroprevalences and co-infections of HIV, hepatitis C virus and hepatitis B virus in injecting drug users in Quetta, Pakistan.

Malik Achakzai1, Masoom Kassi, Pashtoon Murtaza Kasi.   

Abstract

A questionnaire-based survey was administered to a sample of street-recruited injecting drug users. Written informed consent was obtained. Serological screening and further testing for the three blood-borne infections was performed. Fifty (76.9%) consented for serological testing. Seroprevalences of hepatitis C virus (HCV), HIV and hepatitis B antigen were 60%, 24% and 6%, respectively. Co-infections of HCV/HIV were particularly high (20%).

Entities:  

Mesh：

Year:  2007        PMID： 17326891     DOI： 10.1258/004947507779951989

Source DB:  PubMed          Journal:  Trop Doct        ISSN： 0049-4755            Impact factor:   0.731


  16 in total

Review 1.  Communicable disease among displaced Afghans: refuge without shelter.

Authors:  Alefiyah Rajabali; Omer Moin; Amna S Ansari; Mohammad R Khanani; Syed H Ali
Journal:  Nat Rev Microbiol       Date:  2009-08       Impact factor: 60.633

2.  Prevalence of hepatitis C in people who inject drugs in the cities of Rawalpindi and Islamabad, Pakistan.

Authors:  Yasir Waheed; Muzammil Hasan Najmi; Hafsa Aziz; Hasnain Waheed; Muhammad Imran; Sher Zaman Safi
Journal:  Biomed Rep       Date:  2017-08-01

Review 3.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.

Authors:  Abdul Nasir; Catherine S Todd; M Raza Stanekzai; Christian T Bautista; Boulos A Botros; Paul T Scott; Steffanie A Strathdee; Jeffrey Tjaden
Journal:  Int J Drug Policy       Date:  2010-12-10

Review 5.  Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors.

Authors:  Yasir Waheed; Talha Shafi; Sher Zaman Safi; Ishtiaq Qadri
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

Review 6.  Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors.

Authors:  Syed Asad Ali; Rafe M J Donahue; Huma Qureshi; Sten H Vermund
Journal:  Int J Infect Dis       Date:  2008-10-02       Impact factor: 3.623

7.  Prevalence of HCV among the high risk groups in Khyber Pakhtunkhwa.

Authors:  Ijaz Ali; Lubna Siddique; Latif U Rehman; Najib U Khan; Aqib Iqbal; Iqbal Munir; Farzana Rashid; Sana U Khan; Safira Attache; Zahoor A Swati; Mehwish S Aslam
Journal:  Virol J       Date:  2011-06-11       Impact factor: 4.099

8.  Hepatitis B and C prevalence among the high risk groups of Pakistani population. A cross sectional study.

Authors:  Abdul Rauf Memon; Kashif Shafique; Ashraf Memon; Agha Umer Draz; Mohammad Uzair Abdul Rauf; Salahuddin Afsar
Journal:  Arch Public Health       Date:  2012-04-26

9.  Prevalence of HCV among the young male blood donors of Quetta region of Balochistan, Pakistan.

Authors:  Ayesha Khan; Abdul Malik Tareen; Aamer Ikram; Hazir Rahman; Abdul Wadood; Muhammad Qasim; Kalimullah Khan
Journal:  Virol J       Date:  2013-03-13       Impact factor: 4.099

10.  Geographical and temporal variation of injection drug users in Pakistan.

Authors:  Chris P Archibald; Souradet Y Shaw; Faran Emmanuel; Suleman Otho; Tahira Reza; Arshad Altaf; Nighat Musa; Laura H Thompson; James F Blanchard
Journal:  Sex Transm Infect       Date:  2013-01-11       Impact factor: 3.519
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.